B-Cell Responses to Sars-Cov-2 mRNA Vaccines.

Q1 Medicine
Pathogens and Immunity Pub Date : 2022-12-09 eCollection Date: 2022-01-01 DOI:10.20411/pai.v7i2.550
Lela Kardava, Clarisa M Buckner, Susan Moir
{"title":"B-Cell Responses to Sars-Cov-2 mRNA Vaccines.","authors":"Lela Kardava,&nbsp;Clarisa M Buckner,&nbsp;Susan Moir","doi":"10.20411/pai.v7i2.550","DOIUrl":null,"url":null,"abstract":"<p><p>Most vaccines against viral pathogens protect through the acquisition of immunological memory from long-lived plasma cells that produce antibodies and memory B cells that can rapidly respond upon an encounter with the pathogen or its variants. The COVID-19 pandemic and rapid deployment of effective vaccines have provided an unprecedented opportunity to study the immune response to a new yet rapidly evolving pathogen. Here we review the scientific literature and our efforts to understand antibody and B-cell responses to SARS-CoV-2 vaccines, the effect of SARSCoV-2 infection on both primary and secondary immune responses, and how repeated exposures may impact outcomes.</p>","PeriodicalId":36419,"journal":{"name":"Pathogens and Immunity","volume":"7 2","pages":"93-119"},"PeriodicalIF":0.0000,"publicationDate":"2022-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9836209/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pathogens and Immunity","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20411/pai.v7i2.550","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Most vaccines against viral pathogens protect through the acquisition of immunological memory from long-lived plasma cells that produce antibodies and memory B cells that can rapidly respond upon an encounter with the pathogen or its variants. The COVID-19 pandemic and rapid deployment of effective vaccines have provided an unprecedented opportunity to study the immune response to a new yet rapidly evolving pathogen. Here we review the scientific literature and our efforts to understand antibody and B-cell responses to SARS-CoV-2 vaccines, the effect of SARSCoV-2 infection on both primary and secondary immune responses, and how repeated exposures may impact outcomes.

Abstract Image

Abstract Image

b细胞对Sars-Cov-2 mRNA疫苗的应答
大多数针对病毒病原体的疫苗通过从产生抗体的长寿浆细胞和记忆B细胞获得免疫记忆来进行保护,记忆B细胞在遇到病原体或其变体时可以迅速做出反应。新冠肺炎大流行和有效疫苗的快速部署为研究对一种新的快速进化病原体的免疫反应提供了前所未有的机会。在这里,我们回顾了科学文献和我们为了解抗体和B细胞对严重急性呼吸系统综合征冠状病毒2型疫苗的反应、严重急性呼吸系冠状病毒2型感染对初级和次级免疫反应的影响,以及重复暴露可能如何影响结果所做的努力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pathogens and Immunity
Pathogens and Immunity Medicine-Infectious Diseases
CiteScore
10.60
自引率
0.00%
发文量
16
审稿时长
10 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信